U.S. pharma big copyright scrapped two experimental weight loss tablets final yr—a the moment-every day pill, lotiglipron, on account of elevated liver enzymes in addition to a two times-every day pill, danuglipron, resulting from strong Unwanted effects—but CEO Albert Bourla has said the company is decided to “Engage in and acquire” while